Literature DB >> 28386829

Tuberculosis - persistent threat to human health.

Y K Amdekar1.   

Abstract

With the increasing incidence of tuberculosis worldwide, childhood cases now constitute 40% of the total. TB control thus has global importance. Unfortunately, control of disease is not in sight. It was always thought that adult tuberculosis is the fountainhead of childhood tuberculosis but it is being increasingly realized that it is the infection acquired during childhood that promotes reactivation of adult disease, which in turn maintains the chain of transmission.Thus childhood tuberculosis needs equal or more attention for effective control. Early detection by simple tests and ensuring treatment compliance is the goal. The small number of bacilli and inaccessible sites for bacteriological confirmation makes diagnosis of childhood tuberculosis difficult. Circumstantial evidence is often the basis of diagnosis. However, as clinical manifestations depend upon host immune response and virulence of tubercle bacilli, there is no typical clinical presentation. A large number of infected children may remain asymptomatic, undiagnosed and untreated. Conventional tests such as tuberculin test and radiology are not fully dependable and newer tests have limitations. Poor patient treatment compliance contributes to failure of a tuberculosis control program and leads to drug resistance. To combat this, direct observed treatment (DOTS) has been unanimously recommended in treatment of tuberculosis. DOTS is however estimated to be used in less than 40% of new cases. Misconceptions threaten to undermine continued success in tuberculosis control. TB control is essentially a management problem. Greater accountability of governments, donors and providers is essential.

Entities:  

Keywords:  Childhood TB; DOTS; India

Year:  2005        PMID: 28386829     DOI: 10.1007/BF02724017

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  20 in total

1.  Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment.

Authors:  A van Rie; R Warren; M Richardson; T C Victor; R P Gie; D A Enarson; N Beyers; P D van Helden
Journal:  N Engl J Med       Date:  1999-10-14       Impact factor: 91.245

2.  Can eradication of helminthic infections change the face of AIDS and tuberculosis?

Authors:  Z Bentwich; A Kalinkovich; Z Weisman; G Borkow; N Beyers; A D Beyers
Journal:  Immunol Today       Date:  1999-11

3.  Children and tuberculosis: protecting the next generation?

Authors:  P R Donald
Journal:  Lancet       Date:  1999-03-20       Impact factor: 79.321

4.  Directly observed treatment, short-course strategy and multidrug-resistant tuberculosis: are any modifications required?

Authors:  I Bastian; L Rigouts; A Van Deun; F Portaels
Journal:  Bull World Health Organ       Date:  2000       Impact factor: 9.408

5.  Adherence to anti-tuberculosis treatment.

Authors:  M Singh
Journal:  Indian Pediatr       Date:  1999-12       Impact factor: 1.411

Review 6.  Immunology of tuberculosis.

Authors:  J L Flynn; J Chan
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

7.  Role of gastric lavage and broncho-alveolar lavage in the bacteriological diagnosis of childhood pulmonary tuberculosis.

Authors:  M Singh; N V Moosa; L Kumar; M Sharma
Journal:  Indian Pediatr       Date:  2000-09       Impact factor: 1.411

8.  Childhood tuberculosis: out of control?

Authors:  Peter R Donald
Journal:  Curr Opin Pulm Med       Date:  2002-05       Impact factor: 3.155

Review 9.  The diagnosis and management of multiple-drug-resistant-tuberculosis at the beginning of the new millenium.

Authors:  F A Drobniewski; Yanina M Balabanova
Journal:  Int J Infect Dis       Date:  2002-03       Impact factor: 3.623

Review 10.  Tuberculosis control: past 10 years and future progress.

Authors:  Thomas R Frieden; Cynthia R Driver
Journal:  Tuberculosis (Edinb)       Date:  2003       Impact factor: 3.131

View more
  1 in total

1.  XDR TB in a case of IL12Rβ1 deficiency: a case report of Mendelian Susceptibility to Mycobacterial Disease from India.

Authors:  Rashid H Merchant; Javed Ahmed; Noor Ahmad
Journal:  Indian J Pediatr       Date:  2012-06-14       Impact factor: 1.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.